Study to evaluate mk-3655 (H-48663)
Description
Content
A phase 2b randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of mk-3655 in individuals with pre-cirrhotic nonalcoholic steatohepatitis.
Contact
Phone 1: 713–798–1037
IRB: H-48663
Status:
Active
Created:
